ADVERTISEMENT

James Rossen, MD

Original Contribution

Recurrent Cardiovascular Events with Paclitaxel-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Lesions: Insights from the SOS (Stenting of Saphenous Vein Grafts) Trial

05/26/2011

Tesfaldet T. Michael , MD, MPH;

Donald Haagen , RCIS, MD;

Tayo Addo , MD;

Aristotelis C. Papayannis , MD;

Abdul-Rahman Abdel-Karim , MD;

Bilal Saeed , MD;

Panagiotis Karyofillis , MD;

Biswajit Kar , MD;

Peter B. Berger , MD;

Christopher Lichtenwalter , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Owen Obel , MD;

Subhash Banerjee , MD, FSCAI;

Joseph K. Bissett , MD;

Rajesh Sachdeva , MD;

Vassilios V. Voudris , MD, PhD;

Michele Roesle , RN, BSN, MD;

James Rossen , MD;

Bavana V. Rangan , BDS, MPH, MD;

Panayotis Fasseas , MD;

James A. de Lemos , MD;

ABSTRACT: The Stenting of Saphenous Vein Grafts (SOS) trial demonstrated a reduction in clinical and angiographic adverse events with paclitaxel-eluting stents (PES) compared to bare-metal stents (BMS) in saphenous vein graft (SVG) lesions,...

ABSTRACT: The Stenting of Saphenous Vein Grafts (SOS) trial demonstrated a reduction in clinical and angiographic adverse events with paclitaxel-eluting stents (PES) compared to bare-metal stents (BMS) in saphenous vein graft (SVG) lesions,...

ABSTRACT: The Stenting of...

05/26/2011

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement